{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:43:27Z","timestamp":1789548207273,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jocn.2010.01.042","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T08:47:40Z","timestamp":1276332460000},"page":"1165-1168","source":"Crossref","is-referenced-by-count":71,"title":["Inhibition of inducible nitric oxide synthase expression and cell death by (\u2212)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Ji Seon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ja","family":"O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom S.","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2010.01.042_bib1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/01.WNL.0000058760.13152.1A","article-title":"Neuroprotective agents for clinical trials in Parkinson\u2019s disease: a systematic assessment","volume":"60","author":"Ravina","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2010.01.042_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.65.5.781","article-title":"Genetic and environmental risk factors for Parkinson\u2019s disease in a Chinese population","volume":"65","author":"Chan","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2010.01.042_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/aje\/155.8.732","article-title":"Parkinson\u2019s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake","volume":"155","author":"Checkoway","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocn.2010.01.042_bib4","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.ejcn.1601471","article-title":"The relation between single\/double or repeated tea catechin ingestions and plasma antioxidant activity in humans","volume":"56","author":"Kimura","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jocn.2010.01.042_bib5","first-page":"3428","article-title":"Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice","volume":"54","author":"Wang","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.jocn.2010.01.042_bib6","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1073\/pnas.96.8.4524","article-title":"Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea","volume":"96","author":"Haqqi","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jocn.2010.01.042_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0006-2952(01)00813-9","article-title":"Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures","volume":"63","author":"Levites","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jocn.2010.01.042_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jnutbio.2005.10.005","article-title":"Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration","volume":"17","author":"Sutherland","year":"2006","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jocn.2010.01.042_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1096\/fj.04-2915fje","article-title":"Green tea extract and (\u2212)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities","volume":"19","author":"Elbling","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jocn.2010.01.042_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (\u2212)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2010.01.042_bib11","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1046\/j.1471-4159.2003.02291.x","article-title":"Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (\u2212)-epigallocatechin-3-gallate: implications for neurodegenerative diseases","volume":"88","author":"Mandel","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2010.01.042_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0024-3205(02)02347-0","article-title":"Effects of green tea polyphenols on dopamine uptake and on MPP+-induced dopamine neuron injury","volume":"72","author":"Pan","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.jocn.2010.01.042_bib13","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1046\/j.1471-4159.2000.0742213.x","article-title":"Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo","volume":"74","author":"Dehmer","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2010.01.042_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jocn.2010.01.042_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000085385","article-title":"Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway","volume":"14","author":"Mandel","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.jocn.2010.01.042_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0161-813X(02)00079-7","article-title":"Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease in mice by tea phenolic epigallocatechin 3-gallate","volume":"23","author":"Choi","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jocn.2010.01.042_bib17","series-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.jocn.2010.01.042_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson\u2019s disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jocn.2010.01.042_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.jocn.2010.01.042_bib20","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1073\/pnas.051633998","article-title":"Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson\u2019s disease","volume":"98","author":"Vila","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jocn.2010.01.042_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.jocn.2010.01.042_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.jocn.2010.01.042_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jnr.20315","article-title":"(\u2212)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury","volume":"78","author":"Li","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jocn.2010.01.042_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/toxsci\/kfh001","article-title":"Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss-Webster mouse","volume":"76","author":"Goodin","year":"2003","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jocn.2010.01.042_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neulet.2005.03.018","article-title":"(\u2212)-Epigallocatechin gallate as an intervention for the acute treatment of cerebral ischemia","volume":"382","author":"Rahman","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jocn.2010.01.042_bib26","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1210\/en.141.3.980","article-title":"Modulation of endocrine systems and food intake by green tea epigallocatechin gallate","volume":"141","author":"Kao","year":"2000","journal-title":"Endocrinology"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586810002110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586810002110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T02:33:00Z","timestamp":1559183580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586810002110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0967586810002110"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2010.01.042","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}